Literature DB >> 7624342

Chlamydia pneumoniae (TWAR) in coronary arteries of young adults (15-34 years old).

C C Kuo1, J T Grayston, L A Campbell, Y A Goo, R W Wissler, E P Benditt.   

Abstract

An association of Chlamydia pneumoniae with atherosclerosis of coronary and carotid arteries and aorta has been found by seroepidemiology and by demonstration of the organism in atheromata. Age-matched control tissue from persons without atherosclerosis was usually not available. We studied autopsy tissue from young persons, many with no atherosclerosis, to determine whether C. pneumoniae is present in atheroma in young persons with early atherosclerosis and to compare the findings in age- and sex-matched persons without atherosclerosis. A left anterior descending coronary artery sample, formalin-fixed, from 49 subjects, 15-34 years of age, from the multicenter study called Pathobiological Determinants of Atherosclerosis in Youth (PDAY), was examined by immunocytochemistry and the polymerase chain reaction (PCR) for the presence of C. pneumoniae and by PCR for cytomegalovirus. A hematoxylin/eosin-stained section was used to determine disease present in the studied sample. Seven of the artery samples were found to have atheromatous plaque, 11 had intimal thickening, and 31 had no lesions. Eight of the samples were positive for C. pneumoniae by immunocytochemistry (n = 7) and/or PCR (n = 3). Six of the 7 (86%) atheroma, 2 of the 11 (18%) with intimal thickening, and none of the 31 normal-appearing coronary samples were positive. Four were positive by PCR for cytomegalovirus, 2 from diseased arteries and 2 from normal arteries. Examination of the adjacent left coronary artery sample with a fat stain found abnormalities in 25 of the patients, but 19 still showed no evidence of atherosclerosis as a result of either examination. Thus, C. pneumoniae is found in coronary lesions in young adults with atherosclerosis but is not found in normal-appearing coronary arteries of both persons with and without other evidence of atherosclerosis.

Entities:  

Mesh:

Year:  1995        PMID: 7624342      PMCID: PMC41440          DOI: 10.1073/pnas.92.15.6911

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  25 in total

1.  USA Multicenter Study of the pathobiology of atherosclerosis in youth.

Authors:  R W Wissler
Journal:  Ann N Y Acad Sci       Date:  1991       Impact factor: 5.691

2.  PCR amplification from paraffin-embedded tissues. Effects of fixative and fixation time.

Authors:  C E Greer; S L Peterson; N B Kiviat; M M Manos
Journal:  Am J Clin Pathol       Date:  1991-02       Impact factor: 2.493

3.  Serological evidence of an association of a novel Chlamydia, TWAR, with chronic coronary heart disease and acute myocardial infarction.

Authors:  P Saikku; M Leinonen; K Mattila; M R Ekman; M S Nieminen; P H Mäkelä; J K Huttunen; V Valtonen
Journal:  Lancet       Date:  1988-10-29       Impact factor: 79.321

4.  Purification of DNA from formaldehyde fixed and paraffin embedded human tissue.

Authors:  S E Goelz; S R Hamilton; B Vogelstein
Journal:  Biochem Biophys Res Commun       Date:  1985-07-16       Impact factor: 3.575

5.  Southern blot analysis of DNA extracted from formalin-fixed pathology specimens.

Authors:  L Dubeau; L A Chandler; J R Gralow; P W Nichols; P A Jones
Journal:  Cancer Res       Date:  1986-06       Impact factor: 12.701

Review 6.  Chlamydia pneumoniae (TWAR) infections in children.

Authors:  J T Grayston
Journal:  Pediatr Infect Dis J       Date:  1994-08       Impact factor: 2.129

7.  High prevalence of latently present cytomegalovirus in arterial walls of patients suffering from grade III atherosclerosis.

Authors:  M G Hendrix; M M Salimans; C P van Boven; C A Bruggeman
Journal:  Am J Pathol       Date:  1990-01       Impact factor: 4.307

8.  Detection of cytomegalovirus in urine from newborns by using polymerase chain reaction DNA amplification.

Authors:  G J Demmler; G J Buffone; C M Schimbor; R A May
Journal:  J Infect Dis       Date:  1988-12       Impact factor: 5.226

9.  Chlamydia pneumoniae strain TWAR antibody and angiographically demonstrated coronary artery disease.

Authors:  D H Thom; S P Wang; J T Grayston; D S Siscovick; D K Stewart; R A Kronmal; N S Weiss
Journal:  Arterioscler Thromb       Date:  1991 May-Jun

10.  Viruses in the etiology of atherosclerosis.

Authors:  E P Benditt; T Barrett; J K McDougall
Journal:  Proc Natl Acad Sci U S A       Date:  1983-10       Impact factor: 11.205

View more
  63 in total

Review 1.  Chlamydia pneumoniae and atherosclerosis.

Authors:  J D Rutherford
Journal:  Curr Atheroscler Rep       Date:  2000-05       Impact factor: 5.113

Review 2.  Microorganisms in the aetiology of atherosclerosis.

Authors:  S A Morré; W Stooker; W K Lagrand; A J van den Brule; H W Niessen
Journal:  J Clin Pathol       Date:  2000-09       Impact factor: 3.411

Review 3.  Chlamydia pneumoniae and atherosclerosis: critical assessment of diagnostic methods and relevance to treatment studies.

Authors:  Jens Boman; Margaret R Hammerschlag
Journal:  Clin Microbiol Rev       Date:  2002-01       Impact factor: 26.132

4.  T lymphocyte lines isolated from atheromatous plaque contain cells capable of responding to Chlamydia antigens.

Authors:  A J Curry; I Portig; J C Goodall; P J Kirkpatrick; J S Gaston
Journal:  Clin Exp Immunol       Date:  2000-08       Impact factor: 4.330

5.  Specificity of detection of Chlamydia pneumoniae in cardiovascular atheroma: evaluation of the innocent bystander hypothesis.

Authors:  L A Jackson; L A Campbell; R A Schmidt; C C Kuo; A L Cappuccio; M J Lee; J T Grayston
Journal:  Am J Pathol       Date:  1997-05       Impact factor: 4.307

6.  Comments on the failure to detect Chlamydia pneumoniae in atherosclerosis.

Authors:  D Taylor-Robinson; J Boman
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2003-10-23       Impact factor: 3.267

7.  Failure to detect Chlamydia pneumoniae by cell culture and polymerase chain reaction in major arteries of 93 patients with atherosclerosis.

Authors:  J Bishara; S Pitlik; A Kazakov; G Sahar; M Haddad; A Vojdani; S Rosenberg; Z Samra
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2003-05-09       Impact factor: 3.267

8.  Heat-inactivated C. pneumoniae organisms are not atherogenic.

Authors:  Jyotika Sharma; Yuhong Niu; Jianbo Ge; Grant N Pierce; Guangming Zhong
Journal:  Mol Cell Biochem       Date:  2004-05       Impact factor: 3.396

9.  CCL19-CCR7-dependent reverse transendothelial migration of myeloid cells clears Chlamydia muridarum from the arterial intima.

Authors:  Mark Roufaiel; Eric Gracey; Allan Siu; Su-Ning Zhu; Andrew Lau; Hisham Ibrahim; Marwan Althagafi; Kelly Tai; Sharon J Hyduk; Kateryna O Cybulsky; Sherine Ensan; Angela Li; Rickvinder Besla; Henry M Becker; Haiyan Xiao; Sanjiv A Luther; Robert D Inman; Clinton S Robbins; Jenny Jongstra-Bilen; Myron I Cybulsky
Journal:  Nat Immunol       Date:  2016-09-26       Impact factor: 25.606

10.  Chlamydia pneumoniae replicates in Kupffer cells in mouse model of liver infection.

Authors:  Antonella Marangoni; Manuela Donati; Francesca Cavrini; Rita Aldini; Silvia Accardo; Vittorio Sambri; Marco Montagnani; Roberto Cevenini
Journal:  World J Gastroenterol       Date:  2006-10-28       Impact factor: 5.742

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.